Industry in brief | Probi, Karo, Venture Life, RB

19 July 2019 - Deborah Wilkes


Probi and Karo Pharma have released financial results, Venture Life is pushing on with international expansion, and RB has agreed to pay up to USD1.4 billion to settle a US investigation.

Click tags below for more information on topics:

Probi RB Karo Pharma Venture Life

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: